Voltage-gated calcium channels (Ca V s) are large (∼0.5 MDa), multisubunit, macromolecular machines that control calcium entry into cells in response to membrane potential changes. These molecular switches play pivotal roles in cardiac action potentials, neurotransmitter release, muscle contraction, calcium-dependent gene transcription and synaptic transmission. Ca V s possess self-regulatory mechanisms that permit them to change their behaviour in response to activity, including voltage-dependent inactivation, calcium-dependent inactivation and calcium-dependent facilitation. These processes arise from the concerted action of different channel domains with Ca V β-subunits and the soluble calcium sensor calmodulin. Until recently, nothing was known about the Ca V structure at high resolution. Recent crystallographic work has revealed the first glimpses at the Ca V molecular framework and set a new direction towards a detailed mechanistic understanding of Ca V function.
Introduction
Voltage-gated calcium channels (Ca V s) play a unique role in the interplay between electrical and chemical signalling in biological systems [1, 2] . Ca V s respond to membrane depolarization by opening calcium-selective pores. Calcium ion entry causes further membrane potential changes and, because calcium ions act as chemical messengers, may also ignite intracellular signalling cascades. As one of the principal sources of calcium in excitable cells, Ca V s are under intense pressure to control calcium influx and to detect and respond to changes in intracellular calcium concentrations.
Three intrinsic well-characterized processes regulate Ca V s: VDI (voltage-dependent inactivation), CDI (calcium-dependent inactivation) and CDF (calcium-dependent facilitation). VDI and CDI aid in calcium influx termination. CDI and CDF both act in a manner that can be thought of as 'molecular short-term memory', as channels that have already been opened 'remember' this fact and change their inactivation properties or are more readily opened by subsequent stimulation. Despite extensive functional characterization, it is only in the last 3 years that the molecular architecture that underpins VDI, CDI and CDF has begun to be revealed. As Ca V s are major targets for drugs to treat hypertension, arrhythmias and pain [3] , understanding channel architecture in atomic detail has implications that reach far beyond basic science.
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Ca V global architecture
Reconstitution of high-voltage-activated Ca V s (Ca V 1s and Ca V 2s) requires four basic components: Ca V α 1 (Ca V α 1 -subunit), Ca V β, CaM (calmodulin) and Ca V α 2 δ ( Figure 1A ) [1, 4] . Ca V α 1 is the transmembrane subunit (∼1800-2300 amino acids long) that makes the voltage-sensitive, calciumselective pore [1] . Primary structure analysis indicates that Ca V α 1 encodes four homologous repeats that each bears six transmembrane segments. These individual repeats share a common architecture with other members of the voltagegated ion channel superfamily [2] . The first four transmembrane segments of each repeat (segments S1-S4) form the voltage-sensing domain, while the remaining two segments (S5 and S6) form the calcium-selective pore. Approximately half of the Ca V α 1 polypeptide forms the intracellular mass of the channel comprising the N-and C-terminal cytoplasmic domains and three interdomain regions (called the I-II, II-III and III-IV loops). These domains are the sites of action for a range of intracellular regulatory and signalling factors.
The two Ca V intracellular subunits, Ca V β and CaM, bind to the I-II loop and the C-terminal cytoplasmic domain respectively and have prominent roles in VDI, CDI and CDF. Despite the fact that CaM is a highly expressed, ubiquitous protein, both forms, apo-CaM [5] [6] [7] and Ca 2+ /CaM [6] [7] [8] [9] [10] [11] [12] [13] , bind Ca V α 1 . Thus, by virtue of its calcium-independent tethering to Ca V α 1 , CaM can be considered an essential Ca V subunit [14] .
Ca V s have one other essential protein, Ca V α 2 δ [15] . Ca V α 2 δ is made from a single gene product that is proteolytically processed into extracellular (α 2 ) and membrane-spanning (δ) components that remain covalently associated by a disulfide bond. Ca V α 2 δ is required for proper cell-surface expression of Ca V complexes, but whether it also affects the kinetic properties of the channel remains unclear [15] . Perhaps the most interesting Ca V α 2 δ property is that it is the target for gabapentin, an anti-epileptic and analgesic drug that acts via a yet unknown mechanism [16] . A final subunit, Ca V γ , associates with skeletal-muscle calcium channels, but its general importance for other channel types remains uncertain [17] .
The quaternary arrangement of Ca V components remains undefined. Three low-resolution electron microscopy studies of skeletal-muscle Ca V s have yielded very different images [18] [19] [20] . The limited resolution, together with the lack of a consensus, hinders the mechanistic utility of these studies. The present limitations in the use of native Ca V s for highresolution structural studies has inspired a different approach to obtain insight into the structural basis of Ca V function. Division of the channel into functional parts has yielded the first two high-resolution structures of intracellular Ca V components: Ca V β, alone and complexed to a part of the I-II loop [21] [22] [23] , and the Ca 2+ /CaM-Ca V 1.2 IQ (Ile-Gln) domain complex [24, 25] . Like many structural studies, these advances have settled some questions and raised others.
Ca V βs
Ca V βs are approx. 500-amino-acid cytoplasmic proteins that bind to the Ca V I-II intracellular loop [26] and affect channel gating properties [27, 28] , trafficking [29, 30] , regulation by neurotransmitter receptors through G-protein βγ subunit activation [31] and sensitivity to drugs [32] . There are four mammalian isoforms and each has separate effects on Ca V VDI properties [33] . The Ca V β primary sequence encodes five domains, arranged V1-C1-V2-C2-V3. V1, V2 and V3 are variable domains, whereas C1 and C2 are conserved [34] . C1-V2-C2 makes the Ca V β functional core [23, 35, 36] . The principal Ca V β-Ca V α 1 interaction site is a conserved 18-residue sequence in the I-II loop called the AID (α-interaction domain) [37, 38] .
Structural studies reveal that C1 and C2 form an SH3 domain (Src homology 3 domain) and an NK (nucleotide kinase) domain respectively ( Figure 1B ) [21] [22] [23] . The five-stranded SH3 domain has a split architecture in which the last β-strand that completes the fold (β5) occurs in the primary sequence following the V2 domain ( Figure 1B ). Ca V βs share structural features with a family of scaffolding molecules, the MAGUKs (membrane-associated guanylate kinases) [39] , but have some notable differences that include different relative orientation of the SH3 and NK domains as well as the absence of a number of essential MAGUK domains [21] [22] [23] .
The structural work resolved how Ca V β binds the AID. A contiguous 41-amino-acid region, known as the BID (β-interaction domain) [34] , which was thought to be the interaction site, was completely buried in the NK domain core and thus could not be the AID interaction site. Co-crystal structures of Ca V β-AID complexes [21] [22] [23] showed that the AID binds in a conserved, deep groove at the distal end of the Ca V β NK domain [named the ABP (α-binding pocket) [22] ]. The AID interacts with Ca V β through a set of conserved residues that include two aromatic residues that are deeply buried in the ABP ( Figure 1C ).
While the AID-ABP complex forms the high-affinity Ca V β-Ca V α 1 site, there is evidence for lower affinity Ca V β-Ca V α 1 interactions [36, 40] , although recent studies challenge this idea for the I-II loop [41] . By virtue of size (Ca V β ∼55 kDa), the varied effects of Ca V β subtypes on channel gating and the sheer amount of Ca V α 1 cytoplasmic mass (∼1300 amino acids), it is inescapable that there must be other points of Ca V β-Ca V α 1 interaction. Although the exact sites are unknown, the Ca V β 2a crystal structure provides clues to candidate sites. One is the fairly deep groove between the SH3 and NK domains on the Ca V β side that is opposite to the ABP [22] . A second is defined by a site where a small portion of the V2 loop of one subunit in the crystal lattice binds to a hydrophobic pocket on the SH3 domain surface of the adjacent Ca V β ( Figure 1D ) [22] . Such crystallographically defined protein-protein contacts often indicate sites that are in want of a binding partner, even if the observed partner is not the natural one [42] . Finally, the V1, V2 and V3 regions seem likely candidates for elements that alter channel gating through contacts with Ca V α 1 .
Despite extensive functional study, the molecular mechanisms by which Ca V βs act remain imperfectly understood. In addition to the biophysical changes, Ca V α 1 -Ca V β interactions markedly influence cell-surface expression [29, 30] . Control of Ca V trafficking by cellular signalling proteins that regulate Ca V α 1 -Ca V β interactions may provide an important means to modulate cellular excitability [29] . There also remains a question surrounding the role of the Ca V β-AID interactions in Ca V inhibition by G-protein βγ subunits. Biochemical experiments show that G βγ binds the AID peptide, albeit with weaker affinity than Ca V β [43] . The relevance of the G βγ -AID interaction for physiological regulation is unclear and is challenged by the demonstration that key positions required for G βγ -AID interactions are buried deep in the ABP [22] . Whether the mechanism of G βγ regulation of Ca V channels occurs by antagonizing Ca V β binding to the AID or through other mechanisms remains to be determined [31] . Finally, recent studies of Ca V β 3 knockout mice have shown in pancreatic β-cells that Ca V βs have a role in Ca 2+ oscillation modulation that is independent of Ca V α 1 [44] . Defining such 'non-channel' Ca V β functions represents an exciting new direction. Because Ca V channel subtypes are major targets for drugs for cardiovascular disease, migraine and pain [3] , the development of compounds that could interfere with the Ca V α 1 -Ca V β interactions based on structural information may provide new ways to modulate Ca V function in pathological states.
The Ca V Ca 2+ /CaM-IQ domain interaction
Association with CaM endows Ca V s with CDI and CDF properties [14] . The Ca 2+ /CaM target site is part of the Ca V Cterminal cytoplasmic tail known as the IQ domain, a class of domains found in many Ca 2+ /CaM modulated proteins [45] (Figure 2A ). Crystallographic studies have provided the first high-resolution structures of a Ca 2+ /CaM-IQ domain complex [24, 25] and reveal features of the Ca 2+ /CaM-IQ domain interaction that have important consequences for understanding how CDI and CDF work. CaM has two lobes (N-lobe and C-lobe). Both wrap around a helix formed by the Ca V 1.2 IQ domain and each engages a set of three aromatic anchor residues from the IQ domain ( Figures 2B and 2C) . The complex is unusual in that the relative orientation of Ca 2+ /CaM and the IQ helix is the opposite to that in most other Ca 2+ / CaM-peptide complexes. Ca 2+ /CaM binds to the IQ domain helix in a parallel manner in which the N-lobe binds the Nterminal end of the IQ helix, while the C-lobe binds to the C-terminal end rather than in the usual antiparallel mode.
One puzzle in understanding CDI and CDF has been that the action of opposite CaM lobes on the conserved IQ domain has different roles in the Ca V 1s and Ca V 2s [14] . In Ca V 1s, the Ca 2+ /C-lobe controls CDI, but CDI is governed by the Ca 2+ /N-lobe in Ca V 2s. There is a clear role for the Ca 2+ /Clobe in Ca V 2 channel CDF but no previous characterization of the origin of Ca V [24] . The Ca 2+ /C-lobe site matches well what is known regarding the prominence of the Ca 2+ /C-lobe in Ca V 1 CDI [9, 46] . Disruption of the Ca V 1 Ca 2+ /N-lobe binding site by simultaneous mutation of the three N-lobe aromatic anchors to alanine eliminates CDF and indicates a previously unknown role for the Ca 2+ /N-lobe interaction site in Ca V 1 CDF [24] . Together with previous work, this observation suggests that there is an exchange of roles for the two CaM lobes between the two channel types.
How might such a role exchange happen? In light of the structural data, comparison of the IQ domains from Ca V 1s and Ca V 2s reveals six amino acids that are conserved within the subtypes but not between the subtypes ( Figure 2C) . Notably, three positions are aromatic anchor sites. How might these changes cause exchange of N-lobe and C-lobe roles ( Figure 2D )? One possibility is that the differences alter the relative affinities of the lobes for their respective IQ domain binding sites (and by linkage the calcium affinities of the individual CaM lobes) and that these changes tip the balance so that N-lobe binds more tightly in Ca V 2 channels and thereby leads to CDI. Another possibility is that the IQ domain residue differences result in an exchange of binding sites so that in Ca V 2 channels the Ca 2+ /CaM complex binds the IQ domain in the more common antiparallel arrangement ( Figure 2D ). In this way, the CDF site is in the same relative place (at the N-terminal end of the IQ peptide) but occupied by the other CaM lobe. While such a binding site exchange would provide a simple and elegant explanation for the exchange of lobe-specific roles in CDI and CDF, the situation may be more complicated. There are potential roles for apoCaM [13, 47] and CaMKII [48] in binding to the IQ peptide and in CDI and CDF. There may also be other CaM binding sites on Ca V α 1 that affect these processes. Clearly, a Ca 2+ / CaM-Ca V 2 IQ domain structure and structures of larger portions of the C-terminal domain will help clarify the issue.
Intracellular domains and gating
Given the structures of Ca V intracellular components, a key question is how these domains influence the opening and closing of the Ca V pore. The simplest model for understanding Ca V β regulation is that the AID helix is part of a longer helix that continues into the IS6 transmembrane segment ( Figure 3A) . As IS6 is implicated in channel closing, restriction of the movement of IS6 by Ca V β 2a , which is anchored to the membrane by a palmitoylation site at the N-terminus of the V1 segment [26] , may be an important mechanism for slowing channel inactivation. It is less obvious how the other Ca V βs work. Ca V β 1b and Ca V β 3 speed inactivation and Ca V β 4 causes moderate slowing [33] . None of these isoforms has an N-terminal lipid anchor. Because the core SH3 and NK domains are identical, it seems likely that variability in the V1, V2 and V3 segments will be responsible for the other properties via interaction with parts of Ca V α 1 .
The IQ domain is too far in primary sequence from IVS6 to postulate a simple model for how Ca 2+ /CaM effects gating. One interesting question is whether Ca V β and the CaM domain collaborate in some way to affect the movement of a common element in the pore ( Figure 3B ). The possibility that such a linkage happens via the isoleucine residue of the IQ domain [49] is unlikely as this residue is completely buried by the Ca 2+ /C-lobe [24] . There are other large Ca V cytoplasmic regions. Defining interactions between these domains, their structures, their relationships to Ca V β and the CaM/IQ domain and their conformational changes are at the heart of determining how Ca V s work. Eventually, we will need to see the architecture of the entire approx. 0.5 MDa complex and how Ca V s integrate into signalling networks [50] . Until then, pairing the pieceby-piece dissection of Ca V structure with biochemical and functional studies is likely to be fruitful for understanding Ca V design, function and regulation. 
